Is CCRIS 8822 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use CCRIS 8822? Is CCRIS 8822 safe for nursing mother and child? Does CCRIS 8822 extracts into breast milk? Does CCRIS 8822 has any long term or short term side effects on infants? Can CCRIS 8822 influence milk supply or can CCRIS 8822 decrease milk supply in lactating mothers?
CCRIS 8822 lactation summary
- DrLact safety Score for CCRIS 8822 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of CCRIS 8822 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that CCRIS 8822 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using CCRIS 8822 .
- Usage of CCRIS 8822 is in contradiction to breastfeeding hence if it is must to use CCRIS 8822 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About CCRIS 8822 usage in lactation
Drug is cleared from the body in 5 elimination half-lives. Resuming breastfeeding is likely safe after 10 days of pumping-and-dumping.
Answer by DrLact: About CCRIS 8822 usage in lactation
No information is available on the use of CCRIS 8822 during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during CCRIS 8822 therapy and for 3 weeks after the last dose.
Alternate Drugs
Carboplatin(Dangerous)
Hydroxyurea(Low Risk)
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Etoposide(Dangerous)
Fluorouracil(Dangerous)
Doxorubicin(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Cyclophosphamide(Dangerous)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Cisplatin(Unsafe)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Busulfan(Dangerous)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Erlotinib(Unsafe)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Dactinomycin(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Ipilimumab(Unsafe)
Mercaptopurine(Safe)
Cetuximab(Unsafe)
Letrozole(Dangerous)
Exemestane(Dangerous)